Apatinib in patients with advanced chordoma: a single-arm, single-centre, phase 2 study-Reference-Cited by-同舟云学术

Apatinib in patients with advanced chordoma: a single-arm, single-centre, phase 2 study

Published:2020-09 Issue:9 Volume:21 Page:1244-1252
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Liu Chao,Jia Qi,Wei Haifeng,Yang Xinghai,Liu Tielong,Zhao Jian,Ling Yan,Wang Chenguang,Yu Hongyu,Li Zhenxi,Jiao Jian,Wu Zhipeng,Yang Cheng,Xiao Jianru

Publisher

Elsevier BV

Subject

Oncology

Reference29 articles.

1. Chordoma: current concepts, management, and future directions;Walcott;Lancet Oncol,2012

2. Multidisciplinary management of recurrent chordomas;Yamada;Curr Treat Options Oncol,2013

3. Building a global consensus approach to chordoma: a position paper from the medical and patient community;Stacchiotti;Lancet Oncol,2015

4. Management of locally recurrent chordoma of the mobile spine and sacrum: a systematic review;Ailon;Spine,2016

5. Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group;Stacchiotti;Ann Oncol,2017

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase 2 study of a brachyury‐targeting vaccine in combination with radiation therapy for the treatment of advanced chordoma;Cancer;2024-07-10

2. Immune microenvironment and immunotherapy for chordoma;Frontiers in Oncology;2024-06-24

3. Complex immune microenvironment of chordoma: a road map for future treatment;Journal for ImmunoTherapy of Cancer;2024-06

4. The role of systemic therapy in advanced skull base chordomas: overview of the current state and the MD Anderson protocol;Neurosurgical Focus;2024-05

5. Unraveling molecular advancements in chordoma tumorigenesis and treatment response: a review of scientific discoveries and clinical implications;Neurosurgical Focus;2024-05